{"id":1409,"date":"2025-06-03T16:46:21","date_gmt":"2025-06-03T14:46:21","guid":{"rendered":"https:\/\/www.sunrockbiopharma.com\/?p=1409"},"modified":"2025-06-03T16:46:52","modified_gmt":"2025-06-03T14:46:52","slug":"nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas","status":"publish","type":"post","link":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/","title":{"rendered":"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas"},"content":{"rendered":"

SRB2 es un #<\/span>anticuerpo<\/a> monoclonal humanizado desarrollado por SunRock Biopharma, S.L<\/a> cuya diana es #<\/span>CCR9<\/a>.<\/span><\/span><\/p>\n

\ud83c\udfaf Este estudio demuestra la eficacia de SRB2 mediante citotoxicidad celular dependiente de anticuerpos (#<\/span>ADCC<\/a>) en c\u00e9lulas de c\u00e1ncer de p\u00e1ncreas, as\u00ed como su actividad en #<\/span>organoides<\/a> derivados de pacientes y en modelos de #<\/span>xenoinjerto<\/a>, en los que se logra incluso #<\/span>regresi\u00f3n<\/a> #<\/span>tumoral<\/a> completa en un n\u00famero significativo de animales. Estos resultados respaldan el desarrollo de SRB2 como un candidato #<\/span>terap\u00e9utico<\/a> prometedor para el #<\/span>c\u00e1ncer<\/a> de #<\/span>p\u00e1ncreas<\/a>.<\/p>\n

Este trabajo es fruto de una excelente colaboraci\u00f3n entre la University of Kentucky<\/a>, la Universidade de Santiago de Compostela<\/a> (CiMUS (Center for Research in Molecular Medicine and Chronic Diseases)<\/a> y SunRock Biopharma, S.L<\/a>. Estamos muy agradecidos a todos los autores por su contribuci\u00f3n cient\u00edfica. \ud83e\udd1d<\/p>\n

\ud83d\udd17 El art\u00edculo completo aqu\u00ed: https:\/\/lnkd.in\/dk3ZieTH<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

SRB2 es un #anticuerpo monoclonal humanizado desarrollado por SunRock Biopharma, S.L cuya diana es #CCR9. \ud83c\udfaf Este estudio demuestra la eficacia…<\/p>\n","protected":false},"author":1,"featured_media":1406,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"footnotes":""},"categories":[19],"tags":[],"class_list":["post-1409","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"yoast_head":"\r\nNueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas | SunRock Biopharma<\/title>\r\n<meta name=\"robots\" content=\"noindex, follow\" \/>\r\n<meta property=\"og:locale\" content=\"es_ES\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas | SunRock Biopharma\" \/>\r\n<meta property=\"og:description\" content=\"SRB2 es un #anticuerpo monoclonal humanizado desarrollado por SunRock Biopharma, S.L cuya diana es #CCR9. \ud83c\udfaf Este estudio demuestra la eficacia...\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/\" \/>\r\n<meta property=\"og:site_name\" content=\"SunRock Biopharma\" \/>\r\n<meta property=\"article:published_time\" content=\"2025-06-03T14:46:21+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2025-06-03T14:46:52+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2025\/06\/Sin-titulo-1.jpg\" \/>\r\n\t<meta property=\"og:image:width\" content=\"1187\" \/>\r\n\t<meta property=\"og:image:height\" content=\"458\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\r\n<meta name=\"author\" content=\"SunRock\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"SunRock\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/es\\\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/es\\\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\\\/\"},\"author\":{\"name\":\"SunRock\",\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/#\\\/schema\\\/person\\\/4ea2f25ba0ae14f007cd36bc8c8550ea\"},\"headline\":\"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas\",\"datePublished\":\"2025-06-03T14:46:21+00:00\",\"dateModified\":\"2025-06-03T14:46:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/es\\\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\\\/\"},\"wordCount\":172,\"publisher\":{\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/es\\\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Sin-titulo-1.jpg\",\"articleSection\":[\"noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/es\\\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\\\/\",\"url\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/es\\\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\\\/\",\"name\":\"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas | SunRock Biopharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/es\\\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/es\\\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Sin-titulo-1.jpg\",\"datePublished\":\"2025-06-03T14:46:21+00:00\",\"dateModified\":\"2025-06-03T14:46:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/es\\\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sunrockbiopharma.com\\\/es\\\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/es\\\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Sin-titulo-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Sin-titulo-1.jpg\",\"width\":1187,\"height\":458},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/es\\\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/es\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/#website\",\"url\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/\",\"name\":\"SunRock Biopharma\",\"description\":\"Next-Generation Antibodies\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/#organization\",\"name\":\"SunRock Biopharma\",\"url\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/sunrock-seo-fb.png\",\"contentUrl\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/sunrock-seo-fb.png\",\"width\":1201,\"height\":631,\"caption\":\"SunRock Biopharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.sunrockbiopharma.com\\\/#\\\/schema\\\/person\\\/4ea2f25ba0ae14f007cd36bc8c8550ea\",\"name\":\"SunRock\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2059834ffc2a9f5a1ecf5726405930d38e54e30ce53accc78fb262f194614754?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2059834ffc2a9f5a1ecf5726405930d38e54e30ce53accc78fb262f194614754?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2059834ffc2a9f5a1ecf5726405930d38e54e30ce53accc78fb262f194614754?s=96&d=mm&r=g\",\"caption\":\"SunRock\"}}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas | SunRock Biopharma","robots":{"index":"noindex","follow":"follow"},"og_locale":"es_ES","og_type":"article","og_title":"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas | SunRock Biopharma","og_description":"SRB2 es un #anticuerpo monoclonal humanizado desarrollado por SunRock Biopharma, S.L cuya diana es #CCR9. \ud83c\udfaf Este estudio demuestra la eficacia...","og_url":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/","og_site_name":"SunRock Biopharma","article_published_time":"2025-06-03T14:46:21+00:00","article_modified_time":"2025-06-03T14:46:52+00:00","og_image":[{"width":1187,"height":458,"url":"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2025\/06\/Sin-titulo-1.jpg","type":"image\/jpeg"}],"author":"SunRock","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"SunRock","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#article","isPartOf":{"@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/"},"author":{"name":"SunRock","@id":"https:\/\/www.sunrockbiopharma.com\/#\/schema\/person\/4ea2f25ba0ae14f007cd36bc8c8550ea"},"headline":"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas","datePublished":"2025-06-03T14:46:21+00:00","dateModified":"2025-06-03T14:46:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/"},"wordCount":172,"publisher":{"@id":"https:\/\/www.sunrockbiopharma.com\/#organization"},"image":{"@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2025\/06\/Sin-titulo-1.jpg","articleSection":["noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/","url":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/","name":"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas | SunRock Biopharma","isPartOf":{"@id":"https:\/\/www.sunrockbiopharma.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#primaryimage"},"image":{"@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2025\/06\/Sin-titulo-1.jpg","datePublished":"2025-06-03T14:46:21+00:00","dateModified":"2025-06-03T14:46:52+00:00","breadcrumb":{"@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#primaryimage","url":"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2025\/06\/Sin-titulo-1.jpg","contentUrl":"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2025\/06\/Sin-titulo-1.jpg","width":1187,"height":458},{"@type":"BreadcrumbList","@id":"https:\/\/www.sunrockbiopharma.com\/es\/nueva-publicacion-de-sunrock-biopharma-en-molecular-oncology-que-destaca-el-potencial-de-srb2-en-adenocarcinoma-ductal-de-pancreas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sunrockbiopharma.com\/es\/home\/"},{"@type":"ListItem","position":2,"name":"Nueva publicaci\u00f3n de SunRock Biopharma en Molecular Oncology que destaca el potencial de SRB2 en adenocarcinoma ductal de p\u00e1ncreas"}]},{"@type":"WebSite","@id":"https:\/\/www.sunrockbiopharma.com\/#website","url":"https:\/\/www.sunrockbiopharma.com\/","name":"SunRock Biopharma","description":"Next-Generation Antibodies","publisher":{"@id":"https:\/\/www.sunrockbiopharma.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sunrockbiopharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.sunrockbiopharma.com\/#organization","name":"SunRock Biopharma","url":"https:\/\/www.sunrockbiopharma.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.sunrockbiopharma.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2020\/09\/sunrock-seo-fb.png","contentUrl":"https:\/\/www.sunrockbiopharma.com\/wp-content\/uploads\/2020\/09\/sunrock-seo-fb.png","width":1201,"height":631,"caption":"SunRock Biopharma"},"image":{"@id":"https:\/\/www.sunrockbiopharma.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.sunrockbiopharma.com\/#\/schema\/person\/4ea2f25ba0ae14f007cd36bc8c8550ea","name":"SunRock","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/2059834ffc2a9f5a1ecf5726405930d38e54e30ce53accc78fb262f194614754?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2059834ffc2a9f5a1ecf5726405930d38e54e30ce53accc78fb262f194614754?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2059834ffc2a9f5a1ecf5726405930d38e54e30ce53accc78fb262f194614754?s=96&d=mm&r=g","caption":"SunRock"}}]}},"_links":{"self":[{"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/posts\/1409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/comments?post=1409"}],"version-history":[{"count":2,"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/posts\/1409\/revisions"}],"predecessor-version":[{"id":1411,"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/posts\/1409\/revisions\/1411"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/media\/1406"}],"wp:attachment":[{"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/media?parent=1409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/categories?post=1409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sunrockbiopharma.com\/es\/wp-json\/wp\/v2\/tags?post=1409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}